# Francesco Granata

> Francesco Granata is a startup investor at Lupin. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lupin](https://shizune.co/investors/profile/lupin)
- Last updated: Aug 2026

Francesco Granata is a Consultant and Advisor at Helsinn Investment Fund. Francesco joined Circassia as Chairman on 1 September 2013. He is also Chairman of the Nomination Committee.Francesco is senior advisor at Warburg Pincus International LLC. Prior to this, he was Executive Vice President at Biogen Idec Inc., and before that, he was GroupVice President and President responsible for Canada and major European markets at Schering-Plough Corporation. Previously, he served as Regional President for Northern Europe and also the Middle East and Africa at Pfizer Inc., and as Managing Director of Pharmacia & Upjohn Inc. in Italy. He is currently a Board member of Italfarmaco SpA, a leading Italian pharmaceutical group that operates in both the pharma and chemical sectors; Prismic Pharmaceuticals Inc., a US-based medical food company; Quanta Ltd., a UK company that has developed advanced haemodialysis systems for use in the home and clinic; and a member of the strategic advisory committee at Lupin, a leading Indian global pharmaceutical company. Prior to his career in industry, Francesco practiced as a medical doctor specializing in cardiology. He holds a degree in medicine and surgery from the University of Pavia, Italy, and was formerly a member of the Board of the European Federation of Pharmaceutical Industry Associations.

## About Lupin

VC Fund · Mumbai, India

Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of generic and branded formulations and APIs. The Company today has significant presence in Cardiovasculars, Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs in addition to holding global leadership positions in the Anti-TB andCephalosporins space.

5 contacts available at Lupin.

| Name | Title | Profile |
| --- | --- | --- |
| Francesco Granata | Member of the Strategic Advisory Committee | https://shizune.co/investors/profile/francesco-granata |
| Anjan Selz | Vice President & Head of Biosimilars | https://shizune.co/investors/profile/anjan-selz |
| Desh Bandhu Gupta | Founder & Chairman | https://shizune.co/investors/profile/desh-bandhu-gupta-7139 |
| Fabrice Egros | President | https://shizune.co/investors/profile/fabrice-egros |
| Kamal K Sharma | MD | https://shizune.co/investors/profile/kamal-k-sharma |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co